Sell 3/4/2025Downgrade
Neumora Therapeutics, Inc. (NMRA) was downgraded to E+ from D- on 3/4/2025 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 10.75 to 10.29.

Sell 1/22/2025Upgraded
Neumora Therapeutics, Inc. (NMRA) was upgraded to D- from E+ on 1/22/2025 due to an increase in the valuation index.

Sell 1/7/2025Downgrade
Neumora Therapeutics, Inc. (NMRA) was downgraded to E+ from D- on 1/7/2025 due to a decline in the volatility index and total return index.

Sell 12/23/2024Upgraded
Neumora Therapeutics, Inc. (NMRA) was upgraded to D- from E+ on 12/23/2024 due to an increase in the volatility index.

Sell 11/18/2024Downgrade
Neumora Therapeutics, Inc. (NMRA) was downgraded to E+ from D- on 11/18/2024 due to a decline in the solvency index, volatility index and valuation index. The quick ratio declined from 16.14 to 10.75.

Sell 9/26/2024Upgraded
Neumora Therapeutics, Inc. (NMRA) was upgraded to D- from E+ on 9/26/2024 due to an increase in the total return index and volatility index.

Sell 7/12/2024Downgrade
Neumora Therapeutics, Inc. (NMRA) was downgraded to E+ from D- on 7/12/2024 due to a decline in the valuation index and total return index.

Sell 6/27/2024Upgraded
Neumora Therapeutics, Inc. (NMRA) was upgraded to D- from E+ on 6/27/2024 due to an increase in the valuation index.

Sell 6/12/2024Downgrade
Neumora Therapeutics, Inc. (NMRA) was downgraded to E+ from D- on 6/12/2024 due to a decline in the volatility index, solvency index and valuation index. The quick ratio declined from 18.12 to 17.21.

Sell 12/8/2023None
Neumora Therapeutics, Inc. (NMRA) was downgraded to D- from U on 12/08/2023.